EUCRU

Eucrates Biomedical Acquisition Corp. Unit

Delisted

EUCRU was delisted on the 26th of April, 2023.

23 hedge funds and large institutions have $50.9M invested in Eucrates Biomedical Acquisition Corp. Unit in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-14
Holders Change %
-37.84%
% of All Funds
0.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
6
Closed
18
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
CH
26
CVI Holdings
Delaware
-$3.78M -355,000 Closed
SSA
27
Schonfeld Strategic Advisors
New York
-$3.2M -300,000 Closed
MIM
28
Monashee Investment Management
Massachusetts
-$3.2M -300,000 Closed
LIM
29
Longfellow Investment Management
Massachusetts
-$2.14M -200,000 Closed
EC
30
EcoR1 Capital
California
-$2.13M -200,000 Closed
ECM
31
Endurant Capital Management
California
-$2.08M -195,000 Closed
HP
32
Hound Partners
New York
-$1.87M -175,000 Closed
CC
33
Centiva Capital
New York
-$1.65M -154,665 Closed
HI
34
HBK Investments
Texas
-$1.6M -150,000 Closed
AA
35
AQR Arbitrage
Connecticut
-$1.43M -137,500 Closed
RCM
36
Rivernorth Capital Management
Florida
-$1.07M -100,000 Closed
Jane Street
37
Jane Street
New York
-$853K -80,000 Closed
BFM
38
Boothbay Fund Management
New York
-$752K -70,571 Closed
EAM
39
Exos Asset Management
New York
-$112K -10,486 Closed
LCM
40
Landscape Capital Management
New Jersey
-$107K -10,000 Closed
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
-$11K -1,000 Closed